A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
Clinical trial NCT05471856 · RECRUITING
Trial details
- NCT number
- NCT05471856
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-24
- Primary completion
- 2028-09-13
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.